Pancreatic Islet Cell Transplantation - A Novel Approach to Improve Islet Quality and Engraftment
Status:
Completed
Trial end date:
2017-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess a novel approach to immunosuppression in allogenic
pancreatic islet cell transplant recipients. In addition, the study aims to assess remote
site islet processing with culture for pancreatic islet cell transplantation in human
subjects.